When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GWPH - GW Pharmaceuticals Trounces Q3 Estimates -- and Investors Still Weren't Happy
GW Pharmaceuticals Plc
GW Pharmaceuticals' (NASDAQ: GWPH) launch of cannabidiol (CBD) drug Epidiolex has gone exceptionally well so far. The biotech has trounced sales estimates quarter after quarter.
Investors were hoping for continued momentum when GW reported its third-quarter results after the market closed on Tuesday. And that's what they got, although maybe not as much they really wanted. Here are the highlights from the company's Q3 update.